Markets

Health Care Sector Update for 04/02/2015: CNDO

Health care stocks:

JNJ: 0.09%

PFE: +0.32%

ABT: +0.39%

MRK: +0.30%

AMGN: -0.04%

Health-care stocks were slightly higher after Thursday's opening bell.

Coronado Biosciences ( CNDO ) CNDO was up 1.7% after the biopharmaceutical company said it has formed a new subsidiary company, DiaVax Biosciences, to develop immunotherapies for the prevention and treatment of cytomegalovirus.

Medivation ( MDVN ) and Astellas Pharma said top-line results from their phase 2 trial comparing enzalutamide with bicalutamide in men with non-metastatic or metastatic castration-resistant prostate cancer achieved its primary endpoint, demonstrating a statistically significant increase in progression-free survival for enzalutamide compared with bicalutamide. Median progression-free survival was 19.4 months in the enzalutamide group compared with 5.7 months in the bicalutamide group. MDVN was trading down 0.2% early in Thursday's session.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More